Connections The GSK Vaccines site in Siena hosted the annual EMBL in Italy event. The hybrid meeting brought together industry leaders, representatives from biotech start-ups, data scientists, and researchers from academia.
2022
alumniconnections
Science & Technology Scientists develop technology to measure how ATP concentration affects protein solubility in cells
2019
sciencescience-technology
Lab MattersPeople & Perspectives Takeda joins pioneering public-private drug discover collaboration Open Targets
2017
lab-matterspeople-perspectives
Connections Abel Ureta-Vidal and Louise Modis join colleagues and peers at gathering of UK-based alumni
2016
alumniconnections
ConnectionsLab Matters Pioneering target validation collaboration expands to accelerate drug discovery research.
2016
connectionslab-matters
ConnectionsLab Matters Identifying evidence-based relationships between drug targets and diseases.
2015
connectionslab-matters
Lab Matters Career insights from Riccardo Cortese, whose start-up is developing an Ebola vaccine candidate.
2015
alumnilab-matters
Lab Matters Alumni in senior positions in industry share career challenges, highlights and EMBL’s continuing role.
2015
alumnilab-matters
Lab Matters Jeffrey Barrett appointed Director of CTTV, the GSK, EMBL-EBI and Sanger Institute partnership.
2015
lab-matters
ConnectionsLab Matters A new EMBL-EBI biomedical initiative works to determine the best target proteins for new drugs.
2014
connectionslab-matters
No matching posts found
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive
